Table 1.
Demographics and baseline characteristics of patients infected with COVID‐19
| All patients (n = 135) | Mild cases (n = 95) | Severe cases (n = 40) | P value | |
|---|---|---|---|---|
| Characteristics | ||||
| Age, y | 47 (36‐55) | 44 (33‐49) | 56 (52‐73) | <.0001 |
| Sex | ||||
| Men | 72 (53.3%) | 52 (54.7%) | 21 (52.5%) | .9609 |
| Women | 63 (46.7%) | 43 (45.3%) | 19 (47.5) | .9609 |
| Epidemiological | ||||
| Living/traveling in epidemic area | 71 52.6%) | 56 (58.9%) | 15 (37.5%) | .0366 |
| Contact positive patients | 23 (17.0%) | 18 (18.9%) | 5 (12.5%) | .5098 |
| Contact with suspected patients in epidemic area | 19 (14.1%) | 10 (10.5%) | 9 (22.5%) | .1198 |
| No clear contact history | 15 (11.1%) | 9 (9.5%) | 6 (15%) | … |
| Agglomerative disease | 3 (2.2%) | 2 (2.1%) | 1 (2.5%) | … |
| Current smoking | 9 (6.7%) | 8 (8.4%) | 1 (2.5%) | … |
| Any comorbidity | 43 (31.9%) | 15 (16.3%) | 28 (70%) | <.0001 |
| Diabetes | 12 (8.9%) | 3 (3.1%) | 9 (22.5%) | … |
| Cardiovascular disease | 7 (5.2%) | 1 (1%) | 6 (15%) | … |
| Hypertension | 13 (9.6) | 9 (9.4%) | 4 (10%) | … |
| Chronic obstructive | 0 | 0 | 4 (10%) | … |
| Malignancy | 4 (3.0%) | 1 (1%) | 3 (7.5%) | … |
| Pulmonary disease | 1 (0.7%) | 0 | 1 (2.5%) | … |
| Chronic liver disease | 2 (1.5%) | 1 (1%) | 1 (2.5%) | … |
Abbreviation: COVID‐19, coronavirus disease.